B-RAF with PLX4032: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene><br> | <scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene><br> | ||
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene> | |||
<scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> <br> | <scene name='B-RAF_with_PLX4032/Wild-type_b-raf/1'>Wild-Type B-RAF</scene> <br> | ||
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> <br> | <scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> <br> | ||
| Line 12: | Line 13: | ||
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> | <scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> | ||
<applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' /> | <applet load='3og7' size='600' color='white' frame='true' align='left' caption='testcaption' /> | ||
<applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' /> | <applet load='1uwh' size='600' color='white' frame='true' align='right' caption='testcaption' /> | ||
Revision as of 05:31, 5 October 2010
B-RAF with PLX4032B-RAF with PLX4032
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.
|
|